Digestive and Liver Disease

Publicação

Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: a randomized controlled trial

Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1

Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1

Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers ? a role for MMP-9/TIMP-1

Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis